AFAMELANOTIDE
( DrugBank: Afamelanotide / KEGG DRUG: Afamelanotide, Afamelanotide acetate )
2 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 159 | Xeroderma pigmentosum | 6 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 254 | Porphyria | 13 |
159. Xeroderma pigmentosum
Clinical trials : 12 / Drugs : 16 - (DrugBank : 5) / Drug target genes : 7 - Drug target pathways : 17
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
254. Porphyria
Clinical trials : 85 / Drugs : 67 - (DrugBank : 18) / Drug target genes : 18 - Drug target pathways : 28
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|